ADIM
ACAD icon

Alpha DNA Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Alpha DNA Investment Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-16,510
Closed -$517K – 192
2023
Q4 		$517K Buy
+16,510
New +$517K 0.2% 118